Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Serum Albumin, Human | 4 | 2020 | 265 | 2.11 | Why? |
| Trauma Centers | 4 | 2021 | 1195 | 1.03 | Why? |
| Osteoarthritis, Knee | 2 | 2017 | 158 | 1.02 | Why? |
| Pain | 3 | 2018 | 1084 | 0.80 | Why? |
| Chondrogenesis | 1 | 2018 | 19 | 0.77 | Why? |
| Chondrocytes | 1 | 2018 | 35 | 0.76 | Why? |
| Anoikis | 1 | 2018 | 5 | 0.76 | Why? |
| Cell Transdifferentiation | 1 | 2018 | 47 | 0.74 | Why? |
| Vital Signs | 2 | 2017 | 257 | 0.72 | Why? |
| Alcohol-Induced Disorders | 1 | 2017 | 6 | 0.71 | Why? |
| Emergency Medical Services | 3 | 2021 | 3557 | 0.70 | Why? |
| Intracranial Hemorrhages | 2 | 2017 | 1170 | 0.70 | Why? |
| Molecular Weight | 4 | 2020 | 249 | 0.69 | Why? |
| Wounds and Injuries | 3 | 2017 | 1708 | 0.69 | Why? |
| Glycolysis | 1 | 2017 | 208 | 0.64 | Why? |
| Fentanyl | 1 | 2018 | 142 | 0.64 | Why? |
| Ketamine | 1 | 2018 | 112 | 0.63 | Why? |
| Brain Concussion | 1 | 2017 | 113 | 0.62 | Why? |
| Injury Severity Score | 1 | 2017 | 287 | 0.62 | Why? |
| Osteoarthritis | 1 | 2018 | 205 | 0.61 | Why? |
| Administration, Intravenous | 2 | 2018 | 1115 | 0.59 | Why? |
| Transportation of Patients | 1 | 2021 | 494 | 0.58 | Why? |
| Substance Withdrawal Syndrome | 1 | 2017 | 137 | 0.58 | Why? |
| Multiple Trauma | 1 | 2015 | 80 | 0.54 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.54 | Why? |
| Oxidative Stress | 4 | 2017 | 2050 | 0.53 | Why? |
| Hip Fractures | 1 | 2021 | 667 | 0.50 | Why? |
| Subarachnoid Hemorrhage | 1 | 2019 | 611 | 0.50 | Why? |
| Brain Injuries, Traumatic | 1 | 2018 | 381 | 0.49 | Why? |
| Intracranial Thrombosis | 1 | 2017 | 339 | 0.48 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.43 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.41 | Why? |
| Serum Albumin | 1 | 2014 | 571 | 0.40 | Why? |
| Patient Transfer | 1 | 2017 | 898 | 0.40 | Why? |
| Thrombectomy | 2 | 2021 | 2272 | 0.39 | Why? |
| Brain Injuries | 1 | 2015 | 374 | 0.39 | Why? |
| Tissue Plasminogen Activator | 1 | 2016 | 778 | 0.39 | Why? |
| Antioxidants | 3 | 2017 | 1593 | 0.39 | Why? |
| Sepsis | 2 | 2017 | 3517 | 0.38 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.36 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.33 | Why? |
| Time-to-Treatment | 2 | 2021 | 5883 | 0.33 | Why? |
| Stroke | 3 | 2021 | 8839 | 0.31 | Why? |
| Injections, Intra-Articular | 2 | 2017 | 104 | 0.30 | Why? |
| Health Education | 1 | 2017 | 1539 | 0.30 | Why? |
| Academic Medical Centers | 1 | 2017 | 3088 | 0.28 | Why? |
| Pain Measurement | 2 | 2018 | 533 | 0.28 | Why? |
| Oxidation-Reduction | 2 | 2017 | 540 | 0.28 | Why? |
| Fibrinolytic Agents | 1 | 2016 | 1702 | 0.27 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.27 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.26 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.23 | Why? |
| Cytokines | 3 | 2020 | 15010 | 0.23 | Why? |
| Logistic Models | 4 | 2017 | 9089 | 0.23 | Why? |
| Venous Thrombosis | 1 | 2017 | 2739 | 0.23 | Why? |
| Interferon-Stimulated Gene Factor 3 | 1 | 2020 | 22 | 0.22 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.21 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.20 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.20 | Why? |
| Aggrecans | 1 | 2018 | 6 | 0.20 | Why? |
| Collagen Type II | 1 | 2018 | 12 | 0.20 | Why? |
| SOX9 Transcription Factor | 1 | 2018 | 43 | 0.19 | Why? |
| Myocardial Infarction | 1 | 2015 | 3361 | 0.18 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.18 | Why? |
| Alcohol Withdrawal Delirium | 1 | 2017 | 5 | 0.18 | Why? |
| Glycosaminoglycans | 1 | 2018 | 140 | 0.18 | Why? |
| Blood Alcohol Content | 1 | 2017 | 9 | 0.18 | Why? |
| Caspases | 1 | 2018 | 156 | 0.18 | Why? |
| Citric Acid Cycle | 1 | 2017 | 80 | 0.17 | Why? |
| Oxidative Phosphorylation | 1 | 2017 | 120 | 0.17 | Why? |
| Models, Neurological | 1 | 2017 | 121 | 0.17 | Why? |
| Length of Stay | 3 | 2021 | 11042 | 0.16 | Why? |
| Trauma Severity Indices | 1 | 2017 | 176 | 0.16 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.16 | Why? |
| Benchmarking | 1 | 2021 | 627 | 0.16 | Why? |
| Glasgow Coma Scale | 1 | 2017 | 249 | 0.16 | Why? |
| Extracellular Matrix | 1 | 2018 | 189 | 0.16 | Why? |
| Glutathione | 2 | 2017 | 280 | 0.16 | Why? |
| Lipopolysaccharides | 1 | 2020 | 848 | 0.15 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.15 | Why? |
| Glutathione Reductase | 1 | 2015 | 17 | 0.15 | Why? |
| Colorado | 1 | 2017 | 434 | 0.15 | Why? |
| Knee Joint | 1 | 2017 | 194 | 0.15 | Why? |
| Cell Death | 1 | 2018 | 536 | 0.15 | Why? |
| Disability Evaluation | 1 | 2019 | 671 | 0.15 | Why? |
| Thioredoxins | 1 | 2015 | 25 | 0.15 | Why? |
| United States | 5 | 2021 | 46150 | 0.15 | Why? |
| Tomography, X-Ray Computed | 2 | 2019 | 25144 | 0.14 | Why? |
| Cerebral Angiography | 1 | 2017 | 391 | 0.14 | Why? |
| Glutathione Peroxidase | 1 | 2015 | 83 | 0.14 | Why? |
| Syndrome | 1 | 2020 | 1310 | 0.14 | Why? |
| Transcription Factors | 1 | 2020 | 784 | 0.14 | Why? |
| Craniocerebral Trauma | 1 | 2017 | 160 | 0.14 | Why? |
| Running | 1 | 2017 | 153 | 0.14 | Why? |
| Double-Blind Method | 2 | 2017 | 5988 | 0.14 | Why? |
| Humans | 24 | 2021 | 930598 | 0.14 | Why? |
| Superoxide Dismutase | 1 | 2015 | 155 | 0.14 | Why? |
| NAD | 1 | 2015 | 73 | 0.14 | Why? |
| Adult | 13 | 2021 | 244371 | 0.13 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.13 | Why? |
| Wound Healing | 1 | 2018 | 424 | 0.13 | Why? |
| Male | 14 | 2021 | 367725 | 0.13 | Why? |
| NF-kappa B | 1 | 2020 | 1301 | 0.13 | Why? |
| Aged | 10 | 2021 | 215776 | 0.13 | Why? |
| Female | 13 | 2021 | 380317 | 0.12 | Why? |
| Inpatients | 1 | 2009 | 5161 | 0.12 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.12 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.12 | Why? |
| Skilled Nursing Facilities | 1 | 2021 | 1098 | 0.12 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.11 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.10 | Why? |
| Sex Factors | 2 | 2017 | 11014 | 0.10 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.10 | Why? |
| Pain Management | 1 | 2018 | 854 | 0.10 | Why? |
| Inflammation Mediators | 1 | 2020 | 2654 | 0.09 | Why? |
| Thrombolytic Therapy | 1 | 2021 | 2218 | 0.09 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.09 | Why? |
| Recovery of Function | 1 | 2019 | 2461 | 0.09 | Why? |
| Athletes | 1 | 2017 | 1047 | 0.09 | Why? |
| Reactive Oxygen Species | 1 | 2015 | 1136 | 0.09 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.09 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.08 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.08 | Why? |
| Health Status | 1 | 2019 | 3259 | 0.07 | Why? |
| Neurosurgical Procedures | 1 | 2017 | 1738 | 0.07 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.07 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.07 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.07 | Why? |
| Severity of Illness Index | 3 | 2017 | 48226 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Acute Disease | 1 | 2015 | 6029 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Risk Management | 1 | 2009 | 1044 | 0.05 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.05 | Why? |
| Longitudinal Studies | 1 | 2016 | 9893 | 0.05 | Why? |
| Adolescent | 3 | 2017 | 86841 | 0.05 | Why? |
| Young Adult | 3 | 2017 | 93724 | 0.05 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Thiobarbituric Acid Reactive Substances | 1 | 2017 | 20 | 0.04 | Why? |
| Protein Carbonylation | 1 | 2017 | 23 | 0.04 | Why? |
| Catalase | 1 | 2017 | 97 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Hepatectomy | 1 | 2017 | 276 | 0.03 | Why? |
| Forecasting | 1 | 2009 | 4492 | 0.03 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Models, Theoretical | 1 | 2009 | 6659 | 0.03 | Why? |
| Registries | 1 | 2009 | 12327 | 0.02 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
Bar-Or's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_